Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;83(1):90-6.
doi: 10.4269/ajtmh.2010.09-0286.

Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia

Affiliations

Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia

Gonzalo Alvarez et al. Am J Trop Med Hyg. 2010 Jul.

Abstract

Selecting suitable anti-malarial treatment represents one of the best tools for reducing morbidity and mortality caused by this disease. Sexual and asexual parasite dynamics were thus evaluated in patients involved in antimalarial drug efficacy studies by using combined treatment with and without artemisinin derivatives for treating uncomplicated acute Plasmodium falciparum malaria in Antioquia, Colombia. All treatment doses were supervised and administered according to patients' weight; sexual and asexual parasitemia were evaluated during 28- or 42-days follow-up in 468 patients. Artemisinin-based combination therapy showed greater parasiticidal ability, showing a mean asexual parasitemia survival rate of one day and mean gametocyte survival rate of 1-2 days. Sexual and asexual parasitemias were eliminated more quickly and effectively in the group receiving artemisinin-based combination therapy. Adding 45 mg of primaquine to treatment with artesunate and mefloquine reduced gametocyte and asexual parasite survival by one day.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Parasitemia dynamics according to treatment regimen, Colombia. A, Percentage of patients having gametocytes per follow-up day. B, Percentage of patients having ring forms per follow-up day. C, Mean gametocytes per follow-up day. D, Mean ring forms per follow-up day. E, Analysis of gametocyte survival per follow-up day. F, Analysis of ring form survival per follow-up day.

References

    1. WHO-UNICEF . Roll Back Malaria World Malaria Report. Geneva: World Health Organization; 2005. WHO-UNICEF.
    1. WHO . Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization, WHO/CDS/CSR/RMD document; 2003. Geneva.
    1. Suh KN, Kain KC, Keystone JS. Malaria. CMAJ. 170. 2004:1693–1702. - PMC - PubMed
    1. Kremsner PG, Krishna S. Antimalarial combinations. Lancet. 2004;364:285–294. - PubMed
    1. Orjuela P, Gonzalez I, Osorio L. Combination therapy as a strategy to prevent antimalarial drug resistance [in Spanish] Biomedica (Bogota) 2004;24:423–437. - PubMed

MeSH terms